Westfield Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $941M | Sell |
|
|||||
|
2025
Q1 | $854M | Sell |
|
|||||
|
2024
Q4 | $761M | Buy |
|
|||||
|
2024
Q3 | $767M | Buy |
|
|||||
|
2024
Q2 | $677M | Buy |
|
|||||
|
2024
Q1 | $616M | Buy |
|
|||||
|
2023
Q4 | $508M | Buy |
|
|||||
|
2023
Q3 | $356M | Buy |
|
|||||
|
2023
Q2 | $324M | Buy |
|
|||||
|
2023
Q1 | $337M | Sell |
|
|||||
|
2022
Q4 | $386M | Buy |
|
|||||
|
2022
Q3 | $301M | Buy |
|
|||||
|
2022
Q2 | $259M | Buy |
|
|||||
|
2022
Q1 | $309M | Sell |
|
|||||
|
2021
Q4 | $355M | Buy |
|
|||||
|
2021
Q3 | $337M | Buy |
|
|||||
|
2021
Q2 | $265M | Buy |
|
|||||
|
2021
Q1 | $241M | Buy |
|
|||||
|
2020
Q4 | $289M | Sell |
|
|||||
|
2020
Q3 | $276M | Buy |
|
|||||
|
2020
Q2 | $213M | Buy |
|
|||||
|
2020
Q1 | $154M | Buy |
|
|||||
|
2019
Q4 | $175M | Buy |
|
|||||
|
2019
Q3 | $108M | Buy |
|
|||||
|
2019
Q2 | $112M | Buy |
|
|||||
|
2019
Q1 | $80.8M | Buy |
|
|||||
|
2018
Q4 | $33.8M | Sell |
|
|||||
|
2018
Q3 | $41.2M | Buy |
|
|||||
|
2018
Q2 | $28.2M | Buy |
|